NEVVI Medicare utilization intelligence
or

← back

Provider profile

SUDAN, NIMIT M.D.

Hematology-Oncology · NPI 1437199924 · ENCINO, CA

1
Groups
37
Codes · 2024
43,684
Disclosed services

SUDAN, NIMIT is a Hematology-Oncology in ENCINO, CA, a member of 1 medical group, who billed 37 distinct codes to Medicare Part B in 2024.

Groups: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (LOS ANGELES, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

SUDAN, NIMIT billed 30,040 disclosed services in CY2023 and 43,684 in CY2024.

This provider's disclosed Medicare payments across all codes were $ in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1453 Injection, fosaprepitant, 1 mg
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
J7050 Infusion, normal saline solution, 250 cc
96375 Injection of additional new drug or substance into vein
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
96413 Administration of chemotherapy into vein, 1 hour or less
J2469 Injection, palonosetron hcl, 25 mcg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96372 Injection of drug or substance under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96415 Administration of chemotherapy into vein, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99195 Drawing of blood for a medical problem
96361 Infusion into a vein for hydration, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
96523 Irrigation of implanted venous access drug delivery device
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96360 Infusion into a vein for hydration, 31-60 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.